Compass Therapeutics
CMPX
CMPX
72 hedge funds and large institutions have $267M invested in Compass Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
34% less capital invested
Capital invested by funds: $401M → $267M (-$135M)
Holders
72
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.69M | |
| 2 | +$2.93M | |
| 3 | +$2.22M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.55M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.07M |
Top Sellers
| 1 | -$4.7M | |
| 2 | -$3.01M | |
| 3 | -$2.73M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.2M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.59M |